Charles River Launches New Digital Donor Experience

Charles River Laboratories International Inc. has launched a new digital donor experience to enhance access to its donor centers in four distinct US geographic markets.
 
Charles River’s donor center locations, branded as HemaCare Donor Centers, are available coast-to-coast with locations in Northridge, CA, Bothell, WA, Memphis, TN and Lowell, MA.

About The Digital Donor App

The new digital donor app enables users to pre-qualify for donations, seamlessly self-schedule upcoming collection appointments online, and receive automated personal reminders and donation tips. The application results in significant time savings for both the donor and the HemaCare Donor Center recruitment team, creating end-to-end efficiency. This improved experience allows for increased donor engagement, conversion into recallable donors, and growth of a diverse donor pool to more readily serve our clients.
 
In conjunction with the launch of the digital donor application, Charles River aligned its donor-facing HemaCare Donor Center brand nationwide, developed social media messaging campaigns to generate awareness on the value and impact of cellular donations, and created a singular donor center website for streamlining the experience for the prospective donor. This alignment will create consistency that builds trust and loyalty among the donor base.
 
“The HemaCare Donor App exemplifies our continued commitment to improving the donor experience through investments into our technology infrastructure,” commented Birgit Girshick, executive vice president and chief operating officer, Charles River.

Donation Process

HemaCare Donor Centers are FDA-registered, AABB-certified, and state-licensed, working with local donors to contribute critical material to support medical breakthroughs. HemaCare Donor Center locations process a variety of blood products including whole blood, bone marrow, white blood cells (apheresis) and mobilized white blood cells. These cells are collected and used in scientific research, drug development, and manufacturing worldwide for cell therapies. All donations involve complete anonymity, and donors receive compensation for their time.
 
Combined with Charles River’s integrated, early-stage portfolio of research models, discovery, safety assessment and CDMO cell and gene therapy manufacturing services, the Company’s cell solutions services provides a trusted portfolio of fresh and cryopreserved research use, clinical grade, and GMP-compliant cellular products and consultative guidance along with cell processing and isolation services, creating clear pathways for client cell therapy or basic research goals.

Related News

Earlier this week, Charles River Laboratories International Inc. and Nanoscope Therapeutics Inc. announced a comprehensive manufacturing collaboration utilizing Charles River’s extensive contract development and manufacturing (CDMO) services in both plasmid DNA and viral vectors.